Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microarray Patches of Calcipotriol/Betamethasone Dipropionate in Plaque Psoriasis
NCT03898583Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of calcipotriol + betamethasone in plaque psoriasis (4 arms), sponsored by LEO Pharma. Primary endpoints: Overall number of treatment-emergent adverse events at Day 50, Number of treatment-emergent application site reactions at Day 50 and 7 more. Started Apr 2019; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03898583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898583.